ImageneBio Inc(IMA)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-16 | Bonita David P Director | Purchase | +721,292 | +100.00%384,689 | N/A | N/A | View SEC filing | |
| 2026-04-16 | ORBIMED ADVISORS LLC Director | Purchase | +721,292 | +100.00%384,689 | N/A | N/A | View SEC filing | |
| 2025-12-29 | SLATTERY JOSEPH P Director | Purchase | +16,000 | +100.00%16,000 | $5.99 | $95,840 | View SEC filing | |
| 2025-07-30 | Bonita David P Director | Purchase | +83,611 | +40.93%287,885 | $29.90 | $2,499,969 | View SEC filing | |
| 2025-07-30 | Stampacchia Otello Director | Purchase | +267,556 | +142.75%454,982 | $29.90 | $7,999,924 | View SEC filing | |
| 2022-06-24 | ORBIMED ADVISORS LLC Director | Purchase | -252,225 | +5.99%2,098,097 | $4.47 | $1,128,021 | View SEC filing | |
| 2022-06-24 | Bonita David P Director | Purchase | -252,225 | +5.99%2,098,097 | $4.47 | $1,128,021 | View SEC filing | |
| 2022-01-12 | Zhang Xiaoyan Michelle Chief Scientific Officer | Sale | -1,000 | -0.08%44,475 | $12.00 | $12,000 | View SEC filing | |
| 2021-12-14 | FORMELA JEAN FRANCOIS Director | Mixed | +98,722 | +65.67%1,241,935 | $15.77 | $2,385,572 | View SEC filing | |
| 2021-12-14 | Atlas Venture Fund XI, L.P. 10% Owner | Mixed | +98,722 | +4.89%2,116,569 | $15.77 | $2,385,572 | View SEC filing | |
| 2021-12-14 | Zhang Xiaoyan Michelle Chief Scientific Officer | Sale | -1,000 | -2.20%44,475 | $14.76 | $14,760 | View SEC filing | |
| 2021-04-14 | Bonita David P Director | Purchase | +423,400 | -93.81%91,014 | $16.00 | $6,774,400 | View SEC filing | |
| 2021-04-13 | ORBIMED ADVISORS LLC Director | Purchase | +423,400 | -93.81%91,014 | $16.00 | $6,774,400 | View SEC filing | |
| 2021-04-01 | Bonita David P Director | Purchase | +423,400 | -93.54%117,378 | $16.00 | $6,774,400 | View SEC filing | |
| 2021-04-01 | ORBIMED ADVISORS LLC Director | Purchase | +423,400 | -93.54%117,378 | $16.00 | $6,774,400 | View SEC filing |
1-15 of 15